Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Volpicelli Center for Addiction is a specialized medical practice focused on the treatment of alcohol and substance use disorders through evidence-based methods. Founded by Dr. Joseph Volpicelli, a pioneer in the field who led the landmark clinical trials for naltrexone, the center emphasizes a combination of pharmacological intervention and psychosocial support. It is particularly well-known for implementing the Sinclair Method, which utilizes targeted medication to achieve pharmacological extinction of addictive cravings. The center provides outpatient services, including medical consultations, personalized treatment planning, and counseling. Its approach, often referred to as the Volpicelli Model, integrates biological, psychological, and social components to foster long-term recovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Volpicelli Center for Addiction.